01 8BIONPHARMA
02 4CURRAX
01 27332183
02 19693978
03 19693979
04 210022344
05 210028925
06 211090280
07 27332183*PED
01 12Blank
01 10Y
02 2Blank
01 22025-10-02
02 82026-03-03
03 22026-04-02
Patent Expiration Date : 2026-03-03
US Patent Number : 10028925
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1731
Delist Requested :
Patent Use Description : TEMPORARY RELIEF OF MI...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 10022344
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1731
Delist Requested :
Patent Use Description : TEMPORARY RELIEF OF MI...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 10028925
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1732
Delist Requested :
Patent Use Description : TEMPORARY REDUCTION OF...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 10022344
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1732
Delist Requested :
Patent Use Description : TEMPORARY REDUCTION OF...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 11090280
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1731
Delist Requested :
Patent Use Description : TEMPORARY RELIEF OF MI...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 11090280
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code : U-1732
Delist Requested :
Patent Use Description : TEMPORARY REDUCTION OF...
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 9693979
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2026-03-03
US Patent Number : 9693978
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21920
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-03
Patent Expiration Date : 2025-10-02
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
US Patent Number : 7332183
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21926
Patent Use Code : U-867
Delist Requested :
Patent Use Description : TREATMENT OF MIGRAINE
Patent Expiration Date : 2025-10-02
Patent Expiration Date : 2025-10-02
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
US Patent Number : 7332183
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21926
Patent Use Code : U-1719
Delist Requested :
Patent Use Description : ACUTE TREATMENT OF MIG...
Patent Expiration Date : 2025-10-02
LOOKING FOR A SUPPLIER?
